Literature DB >> 24018902

Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.

Maiko Sakamoto1, Steven Paul Woods, Michael Kolessar, Daniel Kriz, J Renee Anderson, Hannah Olavarria, Anna W Sasaki, Michael Chang, Kenneth D Flora, Jennifer M Loftis, Marilyn Huckans.   

Abstract

Higher levels of cognitive reserve (CR) can be protective against the neuropsychological manifestation of neural injury across a variety of clinical disorders. However, the role of CR in the expression of neurocognitive deficits among persons infected with the hepatitis C virus (HCV) is not well understood. Thirty-nine HCV-infected participants were classified as having either high (n = 19) or low (n = 20) CR based on educational attainment, oral word reading, and IQ scores. A sample of 40 demographically comparable healthy adults (HA) was also included. All participants completed the Neuropsychological Assessment Battery, Delis-Kaplan Executive Function System, and Behavioral Rating Inventory of Executive Function, Adult Version (BRIEF-A). Linear regression analyses, controlling for gender, depression, and lifetime substance use disorders, found significant effects of HCV/CR group on verbal fluency, executive functions, and daily functioning T scores, but not in learning or the BRIEF-A. Pairwise comparisons revealed that the HCV group with low CR performed significantly below the HCV high CR and HA cohorts, who did not differ from one another. Findings indicate that higher levels of CR may be a protective factor in the neurocognitive and real-world manifestation of neural injury commonly associated with HCV infection.

Entities:  

Mesh:

Year:  2013        PMID: 24018902      PMCID: PMC3920983          DOI: 10.1007/s13365-013-0196-4

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  46 in total

Review 1.  What is cognitive reserve? Theory and research application of the reserve concept.

Authors:  Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2002-03       Impact factor: 2.892

2.  Neuropsychological impairment in patients with chronic hepatitis C.

Authors:  Robin C Hilsabeck; William Perry; Tarek I Hassanein
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

3.  Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months.

Authors:  M R Basso; R A Bornstein
Journal:  J Clin Exp Neuropsychol       Date:  2000-04       Impact factor: 2.475

4.  Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND).

Authors:  Erin E Morgan; Steven Paul Woods; Christine Smith; Erica Weber; J Cobb Scott; Igor Grant
Journal:  AIDS Behav       Date:  2012-11

Review 5.  Global burden of disease (GBD) for hepatitis C.

Authors: 
Journal:  J Clin Pharmacol       Date:  2004-01       Impact factor: 3.126

6.  Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid.

Authors:  Tomasz Laskus; Marek Radkowski; Agnieszka Bednarska; Jeffrey Wilkinson; Debra Adair; Marek Nowicki; Georgia B Nikolopoulou; Hugo Vargas; Jorge Rakela
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C.

Authors:  Robin C Hilsabeck; Tarek I Hassanein; Meghan D Carlson; Elizabeth A Ziegler; William Perry
Journal:  J Int Neuropsychol Soc       Date:  2003-09       Impact factor: 2.892

8.  Labour force participation among individuals with hepatitis C in the US.

Authors:  Philip Jacobs; Ying Chu Ng; Tania Stafinski; Roger Dodd; Bryce Larke; Winnie Wong
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 9.  Hepatocellular carcinoma: an epidemiologic view.

Authors:  Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2002 Nov-Dec       Impact factor: 3.062

Review 10.  Viral hepatitis C.

Authors:  Thierry Poynard; Man-Fung Yuen; Vlad Ratziu; Ching Lung Lai
Journal:  Lancet       Date:  2003-12-20       Impact factor: 79.321

View more
  4 in total

Review 1.  Cognitive reserve and Alzheimer's disease.

Authors:  Wei Xu; Jin-Tai Yu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

2.  Functional MRI and delay discounting in patients infected with hepatitis C.

Authors:  Holly McCready; Milky Kohno; Michael Kolessar; Laura Dennis; Daniel Kriz; Hannah Luber; Renee Anderson; Michael Chang; Anna Sasaki; Kenneth Flora; Arthur Vandenbark; Suzanne H Mitchell; Jennifer M Loftis; William F Hoffman; Marilyn Huckans
Journal:  J Neurovirol       Date:  2018-10-08       Impact factor: 2.643

Review 3.  Hepatitis C virus infection, and neurological and psychiatric disorders - A review.

Authors:  Lydia Yarlott; Eleanor Heald; Daniel Forton
Journal:  J Adv Res       Date:  2016-09-19       Impact factor: 10.479

Review 4.  Highlighting the Role of Cognitive and Brain Reserve in the Substance use Disorder Field.

Authors:  D Cutuli; D Ladrón de Guevara-Miranda; E Castilla-Ortega; L J Santín; P Sampedro-Piquero
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.